Pasadena Private Wealth LLC lessened its holdings in shares of Nutrien Ltd. (NYSE:NTR – Get Rating) by 30.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,206 shares of the company’s stock after selling 954 shares during the period. Pasadena Private Wealth LLC’s holdings in Nutrien were worth $229,000 at the end of the most recent reporting period.
A number of other large investors have also made changes to their positions in NTR. Retirement Planning Co of New England Inc. purchased a new position in Nutrien during the 4th quarter valued at about $28,000. Dixon Hughes Goodman Wealth Advisors LLC purchased a new position in Nutrien during the 4th quarter valued at about $31,000. Northern Oak Wealth Management Inc. increased its holdings in Nutrien by 57.4% during the 4th quarter. Northern Oak Wealth Management Inc. now owns 417 shares of the company’s stock valued at $31,000 after purchasing an additional 152 shares during the period. Catalyst Capital Advisors LLC increased its holdings in Nutrien by 84.9% during the 4th quarter. Catalyst Capital Advisors LLC now owns 429 shares of the company’s stock valued at $32,000 after purchasing an additional 197 shares during the period. Finally, Alpha Paradigm Partners LLC purchased a new position in Nutrien during the 4th quarter valued at about $59,000. Institutional investors own 64.39% of the company’s stock.
A number of research analysts have weighed in on NTR shares. started coverage on Nutrien in a report on Thursday, April 14th. They set a “buy” rating on the stock. Piper Sandler upped their target price on Nutrien from $112.00 to $125.00 and gave the stock an “overweight” rating in a report on Tuesday, May 31st. Barclays set a $126.00 target price on Nutrien in a report on Monday, June 13th. The Goldman Sachs Group upped their target price on Nutrien from $85.00 to $121.00 and gave the stock a “buy” rating in a report on Wednesday, March 16th. Finally, Scotiabank downgraded Nutrien from a “sector outperform” rating to a “sector perform” rating in a report on Monday, March 28th. Four research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $110.06.
Nutrien (NYSE:NTR – Get Rating) last released its quarterly earnings data on Monday, May 2nd. The company reported $2.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.59 by $0.11. The business had revenue of $7.66 billion for the quarter, compared to analysts’ expectations of $7.77 billion. Nutrien had a return on equity of 20.55% and a net margin of 14.34%. On average, research analysts predict that Nutrien Ltd. will post 16.93 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 15th. Investors of record on Thursday, June 30th will be given a $0.48 dividend. The ex-dividend date of this dividend is Wednesday, June 29th. This represents a $1.92 annualized dividend and a yield of 2.41%. Nutrien’s dividend payout ratio (DPR) is presently 24.65%.
Nutrien Profile (Get Rating)
Nutrien Ltd. provides crop inputs and services. It offers potash, nitrogen, phosphate, and sulfate products; and financial solutions. The company also distributes crop nutrients, crop protection products, seeds, and merchandise products through approximately 2,000 retail locations in the United States, Canada, South America, and Australia.
- Get a free copy of the StockNews.com research report on Nutrien (NTR)
- Accolade Moves Higher But Growth Is Slowing
- ZIM Integrated Shipping Services (ZIM): Don’t Miss This Dividend
- RH Gives Good Reason To Get Defensive
- Why Rio Tinto Group (RIO) Is An Undervalued Opportunity
- Guidewire Software Stock is Set to Rebound
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.